Education
About Us
Working with TipRanks
Follow Us
Jennifer R. Cochran Insider Profile
4 Followers
Jennifer R. Cochran, Former Director at Ligand Pharma, holds 115.27K shares in OmniAb (Ticker: OABI), holds 1.16K shares in Ligand Pharma (Ticker: LGND).
Jennifer R. Cochran Ligand Pharma (LGND)Former Director
Ligand Pharma (LGND)
Former Director
Ranked #30,934 out of 100,956 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+48.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer R. Cochran holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jennifer R. Cochran
Jennifer R. Cochran's Trading History
Ligand Pharma
Nov 03, 2022
Former Director
Uninformative Sell
―
$133.32K
OmniAb
Jul 12, 2024
Director
Uninformative Buy
8.25K
$391.93K
List of latest transactions for each holding click on a transaction to see Jennifer R. Cochran's performance on stock
You May Also Like
Jennifer R. Cochran insider profile FAQ
What is the percentage of profitable transactions made by Jennifer R. Cochran?
The percentage of profitable transactions made by Jennifer R. Cochran is 100%.
What is the average return per transaction made by Jennifer R. Cochran?
The average return per transaction made by Jennifer R. Cochran is 48.90%.
What stocks does Jennifer R. Cochran hold?
Jennifer R. Cochran holds: LGND, OABI stocks.
What was Jennifer R. Cochran’s latest transaction?
Jennifer R. Cochran latest transaction was an Uninformative Buy of $8.25K.
What was Jennifer R. Cochran's most profitable transaction?
Jennifer R. Cochran’s most profitable transaction was an Informative Buy of OABI stock on November 14, 2022. The return on the trade was 62.40%.
What is Jennifer R. Cochran's role in Ligand Pharma?
Jennifer R. Cochran's role in Ligand Pharma is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.